Trilliant Health raises $12m Series A funding

Trilliant Health, a Nashville-based healthcare analytics company, has completed Series A financing of over $12 million, consisting of more than $7 million of new equity capital.

The funding was led by Noro-Moseley Partners, with participation from existing investors Martin Ventures, Nashville Capital Network, and NueCura Partners.

Trilliant said it will use the funding to continue building its data science and technology teams to enhance the capabilities of its analytics platform.

The company's analytics platform uses advanced data science to combine claims data, household data, and user-generated data from digital marketing campaigns to support healthcare systems around strategy, site selection, M&A, payer negotiations, physician relationship management, marketing, and employer relationship management. Trilliant currently works with over 60 healthcare systems across the US to build and execute on their growth strategies.

Hal Andrews, CEO of Trilliant Health, said: “In an environment of relentless reimbursement cuts, rising expenses, and increasing competition, healthcare providers need strategies to find the most efficient and effective solutions for growth more than ever. Trilliant is that growth partner for health systems and other healthcare providers. This capital will help us achieve our goals.”